TALPHERA, INC. Shareholders' Equity
TALPHERA, INC. (TLPH) had Shareholders' Equity of $14.41 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $14.41M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $18.48M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $17.04M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $19.18M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $14.41M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $18.48M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $17.04M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $19.18M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $6.63M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $5.60M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $8.00M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $9.64M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $12.73M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $16.33M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $14.11M 10-K · filed 2026-03-23 |
| 2023-09-30 | $18.31M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $10.42M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $14.24M 10-Q · filed 2024-11-13 |
| 2022-12-31 | $21.81M 10-K · filed 2025-03-31 |
| 2022-09-30 | $27.23M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $33.14M 10-Q · filed 2023-11-14 |
| 2022-03-31 | -$38.27M 10-Q · filed 2023-11-14 |
| 2021-12-31 | -$35.89M 10-K · filed 2024-03-06 |
| 2021-09-30 | -$43.02M 10-Q · filed 2022-11-14 |
| 2021-06-30 | -$35.99M 10-Q · filed 2022-11-14 |
| 2021-03-31 | -$27.31M 10-Q · filed 2022-11-14 |
| 2020-12-31 | -$55.75M 8-K · filed 2023-08-01 |
| 2020-09-30 | -$57.85M 10-Q · filed 2021-11-15 |
| 2020-06-30 | -$60.13M 10-Q · filed 2021-11-15 |
| 2020-03-31 | -$55.28M 10-Q · filed 2021-11-15 |
| 2020-03-01 | -$55.28M 10-Q · filed 2021-05-17 |
| 2019-12-31 | -$41.42M 10-K · filed 2022-03-10 |
| 2019-09-30 | -$28.27M 10-Q · filed 2020-11-05 |
| 2019-06-30 | -$18.42M 10-Q · filed 2020-11-05 |
| 2019-03-31 | -$7.89M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $4.25M 10-K · filed 2021-03-15 |
| 2018-09-30 | -$37.79M 10-Q · filed 2019-11-07 |
| 2018-06-30 | -$48.97M 10-Q · filed 2019-11-07 |
| 2018-03-31 | -$46.88M 10-Q · filed 2019-11-07 |
| 2017-12-31 | -$36.51M 10-K · filed 2021-03-15 |
| 2017-09-30 | -$30.31M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$31.62M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$19.66M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$5.34M 10-K · filed 2020-03-16 |
| 2016-09-30 | $3.27M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $13.50M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $23.44M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $33.11M 10-K · filed 2019-03-07 |
| 2015-09-30 | $39.97M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $33.39M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $41.09M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $46.66M 10-K · filed 2018-03-09 |
| 2014-09-30 | $59.08M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $55.55M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $65.06M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $73.16M 10-K · filed 2017-03-03 |
| 2013-09-30 | $53.20M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $6.04M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $21.92M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $33.85M 10-K · filed 2016-03-07 |
| 2012-09-30 | -$327.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $7.63M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $11.03M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $17.47M 10-K · filed 2015-03-13 |
| 2011-09-30 | $23.36M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $28.41M 10-Q · filed 2011-08-11 |
| 2010-12-31 | -$65.89M 10-K · filed 2014-03-17 |
| 2009-12-31 | -$52.99M 10-K · filed 2013-03-12 |
| 2008-12-31 | -$33.34M 10-K · filed 2013-03-12 |
| 2007-12-31 | -$13.19M 10-K · filed 2013-03-12 |
| 2006-12-31 | -$3.71M 10-K · filed 2013-03-12 |
| 2005-12-31 | -$40.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |